This information was published on 2026-05-28T12:55:57 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2650994 (IR 1916229) |
| (220) |
24 Feb 2026
|
| (300) |
US, 26 Aug 2025, 99357982
|
| (500) |
The mark consists of a squiggly design element to the left of the word "callio" that is above the word "THERAPEUTICS".
|
| (511) (510) |
Class 5
Pharmaceutical and biological preparations; pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; pharmaceutical and biological preparations for use in oncology. Class 40 Custom manufacturing of pharmaceuticals and therapeutic agents for medical use. Class 42 Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; scientific investigations for medical purposes featuring clinical trials. |
| (540) |
|
| (550) | Figurative |
| (730) |
Callio Operating Co, Inc.
|
Find out more about publications on the About page.